Watchlist Price Alert

HTG Molecular Diagnostics... (HTGM)

NASDAQ: HTGM · Real-Time Price · USD

0.48

0.00 (0.00%)

At close: Jun 14, 2023, 8:00 PM

HTG Molecular Diagnostics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-21.59M	-17.15M	-20.87M	-19.3M	-16.45M	-18.96M	-26.04M
Depreciation & Amortization	587.14K	721.25K	1.35M	1.74M	1.47M	1.24M	1.47M
Stock-Based Compensation	814.51K	1.38M	1.81M	1.22M	n/a	n/a	n/a
Other Working Capital	-429.61K	728.03K	-1.45M	-2.06M	-984.92K	2.48M	391.64K
Other Non-Cash Items	1.93M	890.98K	895.59K	-34.15K	-160.16K	907.48K	1.62M
Deferred Income Tax	n/a	-1.36M	680.75K	162.78K	n/a	n/a	n/a
Change in Working Capital	-143.19K	-989.75K	-156.57K	-485.51K	25.03K	-1.2M	-292.7K
Operating Cash Flow	-18.41M	-16.51M	-16.29M	-16.7M	-13.17M	-16.57M	-22.23M
Capital Expenditures	-23.04K	-644.38K	-453.55K	-1.1M	-949.51K	-1.02M	-1.95M
Cash Acquisitions	n/a	-25.02B	-72.5M	-325.67B	-412.44B	n/a	172.04M
Purchase of Investments	-7.61M	-18.62M	-12.47M	-34.6M	-53.97M	n/a	-3.38M
Sales Maturities Of Investments	19.95M	12.6M	31.65M	32.2M	31.7M	4.3M	29.75M
Other Investing Acitivies	104K	25.02B	72.5M	325.67B	412.44B	n/a	-172.04M
Investing Cash Flow	12.42M	-6.66M	18.73M	-3.5M	-23.22M	3.28M	24.42M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	8.6M	10,391.6B	9.05M	19.39M	38.13M	15.75M	2.03M
Financial Cash Flow	8.6M	10.39M	9.05M	19.39M	38.13M	15.75M	2.03M
Net Cash Flow	2.61M	-12.8M	11.51M	-812.85K	1.73M	2.46M	4.21M
Free Cash Flow	-18.43M	-17.15M	-16.75M	-17.8M	-14.12M	-17.59M	-24.18M